TCIM
VTAE

TIAA CREF Investment Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

TIAA CREF Investment Management’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-103,405
Closed -$2.16K – 3155
2016
Q3 		$2.16K Sell
103,405
-1,079
-1% -$12.4K ﹤0.01% 2131
2016
Q2 		$1.13M Buy
104,484
+65,850
+170% +$563K ﹤0.01% 2445
2016
Q1 		$256K Sell
38,634
-6,829
-15% -$62.1K ﹤0.01% 2943
2015
Q4 		$823K Buy
45,463
+8,594
+23% +$118K ﹤0.01% 2696
2015
Q3 		$406K Buy
36,869
+10,680
+41% +$113K ﹤0.01% 2946
2015
Q2 		$377K Buy
26,189
+9,388
+56% +$127K ﹤0.01% 3030
2015
Q1 		$197K Buy
16,801
+5,174
+44% +$69.8K ﹤0.01% 3061
2014
Q4 		$193K Buy
+11,627
New +$170K ﹤0.01% 3097

TIAA CREF Investment Management's VTAE Position: Q4 2016 in Review

TIAA CREF Investment Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 103,405 shares — an estimated $2.16K sold.

TIAA CREF Investment Management first reported a position in VTAE in Q4 2014 and held it in 8 quarters. The position peaked at $1.13M in Q2 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • TIAA CREF Investment Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • TIAA CREF Investment Management sold 103,405 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $2.16K.
  • TIAA CREF Investment Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2014 and held it in 8 quarters.
  • TIAA CREF Investment Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $1.13M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on TIAA CREF Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.